Risk Factors and Clinical Results of the COVID-19 Pandemic\'s Effect on Pediatric Epilepsy Seizure Control

Begley Dagar^*
*Correspondence: Begley Dagar, Department of Internal Medicine, Korea, Republic of, Email:

Introduction

The COVID-19 pandemic has had widespread and varied impacts on the global population, with significant implications for healthcare systems, social structures and individual health. Among the many groups affected by the pandemic, children with epilepsy have faced unique challenges, particularly in relation to seizure control. Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures and it can significantly impact a child's development, quality of life and overall health. Seizure management for children with epilepsy typically requires careful medical supervision, consistent medication adherence and regular follow-up appointments. However, the COVID-19 pandemic disrupted many of these essential aspects of care, leading to concerns about how these disruptions affected seizure control and the overall health of pediatric epilepsy patients. This essay provides a comprehensive review of the risk factors and clinical outcomes of the COVID-19 pandemic on pediatric epilepsy seizure control, exploring the changes in healthcare delivery, the psychological effects of the pandemic and the potential long-term consequences for children with epilepsy [1,2].

Description

One of the primary concerns during the COVID-19 pandemic was the disruption of routine healthcare services, including the management of chronic conditions such as epilepsy. Pediatric epilepsy patients rely heavily on regular medical visits for routine check-ups, medication management and adjustments to their treatment plans. However, the pandemic led to significant challenges in maintaining consistent healthcare services, as hospitals and clinics were overwhelmed with COVID-19 cases and many routine medical appointments were either postponed or transitioned to telemedicine. These changes in healthcare delivery systems created a precarious situation for children with epilepsy, as interruptions to their regular care could directly impact seizure control. As the pandemic progressed, studies began to assess the long-term effects of COVID-19-related disruptions on pediatric epilepsy patients. Preliminary evidence suggests that the COVID-19 pandemic has led to an increase in seizure frequency and severity in some children, particularly those who experienced prolonged periods of stress, isolation and disruptions to their care. A study conducted in 2020 found that nearly 30% of children with epilepsy experienced an increase in seizure frequency during the early months of the pandemic. This increase in seizure activity was linked to factors such as increased stress, changes in daily routines and difficulty adhering to medication regimens. Additionally, children with epilepsy who had underlying comorbidities, such as intellectual disabilities or autism spectrum disorder, were found to be more vulnerable to the negative effects of the pandemic, as they may have faced greater challenges in adapting to changes in their routines or accessing care.

Conclusion

The COVID-19 pandemic has had a profound impact on children with epilepsy, particularly in relation to seizure control. The disruptions to healthcare delivery, medication management and social support systems have contributed to worsened seizure outcomes for some children, while the psychological stress and social isolation associated with the pandemic have further complicated the management of this chronic condition. While the full extent of the pandemic's impact on pediatric epilepsy remains to be seen, it is clear that the pandemic has highlighted the need for flexible, accessible healthcare systems that can support children with chronic conditions during times of crisis. As the world moves forward from the pandemic, it is essential that healthcare providers continue to monitor the long-term effects on children with epilepsy and prioritize strategies that promote consistent care, medication adherence and mental well-being in order to optimize seizure control and improve the overall quality of life for children living with epilepsy.

References

1. Dagar, Anjali and Tatiana Falcone. "Psychiatric comorbidities in pediatric epilepsy." Curr Psychiatry Rep 22 (2020): 1-10.

Google Scholar, Crossref, Indexed at

2. Begley, Charles E. and Ettore Beghi. "The economic cost of epilepsy: A review of the literature." Epilepsia 43 (2002): 3-9.

Google Scholar, Crossref, Indexed at